Abstract
Understanding the molecular aberrations driving the inception and progression of desmoid tumors (DTs) is crucial to devising an effective management for these neoplasms. The APC/β-catenin pathway is known to be deregulated in DT. This chapter illuminates the molecular mechanisms of APC/β-catenin pathway signaling, elucidates the potential deregulations and mutations at play in DTs, and most importantly evaluates the possible implications of this pathway on DT diagnosis, prognosis, and therapy.
Original language | English |
---|---|
Title of host publication | Desmoid Tumors |
Publisher | Springer Netherlands |
Pages | 29-46 |
Number of pages | 18 |
ISBN (Electronic) | 9789400716858 |
ISBN (Print) | 9789400716841 |
DOIs | |
State | Published - 1 Jan 2012 |
Externally published | Yes |
Keywords
- APC
- Mutations
- Prognostic biomarkers
- Sequencing
- Targeted therapy
- β-Catenin